Trade Pharming Group N.V. - PHAR CFD

Trading Conditions

• Type: CFD
• Spread: 0.011
• Long position overnight funding adjustment: -0.01661%
• Short position overnight funding adjustment: -0.00561%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: EUR
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: Netherlands
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 1.326
• Open: 1.329
• 1-Year Change: 66.75%
• Day's Range: 1.327 - 1.364

What is Pharming Group (PHAR)?

Pharming Group is a biopharmaceutical company specializing in the development and commercialization of innovative protein replacement therapies. The company focuses on rare diseases and unmet medical needs, utilizing recombinant DNA technology to produce therapeutic proteins. Pharming Group’s portfolio includes products targeting conditions such as hereditary angioedema and other genetic disorders. It operates research and manufacturing facilities and collaborates with healthcare providers to deliver treatments globally. The company emphasizes clinical development, regulatory compliance, and expanding access to its therapies.

Pharming Group Stock Price Today: Live Overview

The price today is shaped by live market pricing, showing Pharming Group at €1.370. The session range has stretched from €1.323 to €1.365, with a daily change percentage of +2.4078%.

FAQ: Pharming Group (PHAR)

What is the current price of PHAR stock?

The current trading price is €1.370.

Does PHAR pay dividends?

Pharming Group pays dividends to its shareholders.

Does PHAR have a formal corporate presence or regional headquarters in the UAE?

Pharming Group does not have an official presence in the UAE and operates via distributors.

What is PHAR best known for?

Pharming Group is most famous for its development of treatments for rare diseases.

What assets are typically shown together with PHAR?

Commonly shown alongside PHAR: Paradigm Biopharmaceuticals Limited, Ituran Location and Control Ltd, Royalty Pharma plc